Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,435,837
-$14,265,646 QoQ
Shares Held
339,607
-62.0% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. IMVT ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in IMVT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,435,837 | 339,607 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,701,483 | 893,056 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,297,893 | 204,584 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $977,824 | 61,114 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,724,256 | 744,544 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,695,511 | 916,250 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,469,901 | 1,209,046 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $35,947,533 | 1,361,649 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $60,162,608 | 1,862,043 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $67,515,936 | 1,602,562 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $28,026,311 | 730,042 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $370,446 | 19,528 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,874,093 | 443,204 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,898,981 | 275,999 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $197,089 | 22,680 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $186,063 | 17,603 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $276,818 | 17,258 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,394,545 | 289,988 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,233,304 | 205,550 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||